Kane Biotech Inc. (Kane) is a biotechnology company. Kane is engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company�s technology for the chronic wound care market is DispersinB. The Company�s product for the prevention of catheter-associated infections is Aledex. The Company�s products include urinary catheter coating, venous catheter coating, veterinary catheter coating, topical wound gel, and toothpaste and mouthwash. On May 31, 2011, the Company announced that it got a contract from the United States Army Dental and Trauma Research Detachment (USADTRD) to develop an antibiofilm-antimicrobial wound gel formulation consisting of Kane�s DispersinB antibiofilm enzyme and the United States Army�s KSL-W antimicrobial peptide. On February 1, 2011, Kane announced that it had developed the DispersinB enzyme-linked immunosorbent assay (ELISA) kit.